Page 2 - Recursion Orphan Drug Designation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SALT LAKE CITY, July 21, 2022 /PRNewswire/ Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced that the

Salt lake cityUnited statesUnited kingdomMeredith brown tuttleExchange commissionRegulatory affairsEuropean unionEuropean commissionDrug administrationRecursion orphan drug designationVice presidentOrphan drug designationOrphan drugFast trackRecursion operating systemRecursion data